Shigella flexneri is an intracellular pathogen that deploys an arsenal of virulence factors promoting host cell invasion, intracellular multiplication and intra- and inter-cellular dissemination. We have previously reported that the interaction between apyrase (PhoN2), a periplasmic ATP-diphosphohydrolase, and the C-terminal domain of the outer membrane (OM) protein OmpA is likely required for proper IcsA exposition at the old bacterial pole and thus for full virulence expression of Shigella flexneri (Scribano et al., 2014). OmpA, that is the major OM protein of Gram-negative bacteria, is a multifaceted protein that plays many different roles both in the OM structural integrity and in the virulence of several pathogens. Here, by using yeast two-hybrid technology and by constructing an in silico 3D model of OmpA from S. flexneri 5a strain M90T, we observed that the OmpA residues 188EVQ190 are likely essential for PhoN2-OmpA interaction. The 188EVQ190 amino acids are located within a flexible region of the OmpA protein that could represent a scaffold for protein-protein interaction.
The quantum interference between the decays of entangled neutral kaons is studied in the process ϕ → KSKL → π+π−π+π−, which exhibits the characteristic Einstein-Podolsky-Rosen correlations that prevent both kaons to decay into π+π− at the same time. This constitutes a very powerful tool for testing at the utmost precision the quantum coherence of the entangled kaon pair state, and to search for tiny decoherence and $$ \mathcal{CPT} $$
CPT
violation effects, which may be justified in a quantum gravity framework.The analysed data sample was collected with the KLOE detector at DAΦNE, the Frascati ϕ-factory, and corresponds to an integrated luminosity of about 1.7 fb−1, i.e. to about 1.7 × 109ϕ → KSKL decays produced. From the fit of the observed ∆t distribution, being ∆t the difference of the kaon decay times, the decoherence and $$ \mathcal{CPT} $$
CPT
violation parameters of various phenomenological models are measured with a largely improved accuracy with respect to previous analyses.The results are consistent with no deviation from quantum mechanics and $$ \mathcal{CPT} $$
CPT
symmetry, while for some parameters the precision reaches the interesting level at which — in the most optimistic scenarios — quantum gravity effects might show up. They provide the most stringent limits up to date on the considered models.
The quantum interference between the decays of entangled neutral kaons is studied in the process φ → K S K L → π + π − π + π − , which exhibits the characteristic Einstein-Podolsky-Rosen correlations that prevent both kaons to decay into π + π − at the same time. This constitutes a very powerful tool for testing at the utmost precision the quantum coherence of the entangled kaon pair state, and to search for tiny decoherence and CPT violation effects, which may be justified in a quantum gravity framework.The analysed data sample was collected with the KLOE detector at DAΦNE, the Frascati φ-factory, and corresponds to an integrated luminosity of about 1.7 fb −1 , i.e. to ∼ 1.7 × 10 9 φ → K S K L decays. From the fit of the observed ∆t distribution, being ∆t the difference of the kaon decay times, the decoherence and CPT violation parameters of various phenomenological models are measured with a largely improved accuracy with respect to previous analyses.The results are consistent with no deviation from quantum mechanics and CPT symmetry, while for some parameters the precision reaches the interesting level at which -in the most optimistic scenarios -quantum gravity effects might show up. They provide the most stringent limits up to date on the considered models.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.